The 17 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 210.00, with a high estimate of 250.00 and a low estimate of 176.00. The median estimate represents a +20.89% increase from the last price of 173.71.
The current consensus among 17 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $3.52
Reporting Date Aug 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.